Mesenchymal Stem/Stromal Cells: CONSIDERATION OF COMPARTMENT EFFECT ON BIOMARKER ANALYSIS: LESSONS LEARNED FROM BRAINSTORM’S PHASE III CLINICAL TRIAL EVALUATING MSC-NTF CELL THERAPY IN ALS

N. Blondheim-Shraga, H. Kaspi, Y.S. Levy, Y. Gothelf, N. Goyal, J. Berry, N. Staff, R. Kern, B. Boulanger,R. Aricha, J. Li, N. Abramov, J. Katz,R. Miller, A. Windebank, R. Bowser,M. Cudkowicz, R. Brown, S. Lindborg

Cytotherapy（2023）

引用 0|浏览6